Omicron-specific boosters are on the way

The Food and Drug Administration advised Thursday that vaccine manufacturers tailor upcoming booster shots to the currently circulating Omicron variants. The jabs could be ready by this fall.
 
The FDA decision followed an advisory committee vote just days earlier that made the same recommendation. It paves the way for Pfizer, Moderna, and Novavax — once authorized — to incorporate elements specific to the newer strains into the vaccines.